Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regeneron Pharmaceuticals Inc (REGN)  
$1,051.03 0.17 (0.02%) as of 4:30 Fri 6/28


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 104,690,000
Market Cap: 110.03(B)
Last Volume: 750,617 Avg Vol: 759,306
52 Week Range: $692.45 - $1071.19
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  150
Guru Rank Value     : 6.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 192,108 255,165 311,759 469,743
Total Sell Value $188,697,290 $247,812,013 $294,950,701 $405,465,351
Total People Sold 7 14 16 18
Total Sell Transactions 18 43 67 128
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 2430
  Page 49 of 98  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Poon Christine A Director   –       •      –    2015-08-12 4 S $564.16 $63,186 D/D (112) 790     -
   Poon Christine A Director   –       •      –    2015-08-11 4 D $574.57 $128,129 D/D (223) 902     -
   Poon Christine A Director   –       •      –    2015-08-11 4 OE $273.67 $128,625 D/D 470 1,125     -
   Terifay Robert J SVP Commercial   •       –      –    2015-08-06 4 S $585.22 $7,905,781 D/D (13,423) 23,293     -
   Gilman Alfred G Director   –       •      –    2015-08-06 4 S $582.15 $2,935,601 D/D (5,000) 8,912     -
   Gilman Alfred G Director   –       •      –    2015-08-06 4 OE $57.11 $285,550 D/D 5,000 13,912     -
   Van Plew Daniel P SVP & General Mgr Industrial O   •       –      –    2015-08-06 4 S $582.12 $2,353,807 D/D (4,028) 0     -
   Terifay Robert J SVP Commercial   •       –      –    2015-08-05 4 D $588.64 $9,308,164 D/D (15,813) 36,716     -
   Terifay Robert J SVP Commercial   •       –      –    2015-08-05 4 OE $30.63 $995,475 D/D 32,500 52,529     -
   Van Plew Daniel P SVP & General Mgr Industrial O   •       –      –    2015-08-05 4 D $588.64 $2,750,126 D/D (4,672) 4,028     -
   Van Plew Daniel P SVP & General Mgr Industrial O   •       –      –    2015-08-05 4 OE $21.25 $228,070 D/D 8,700 6,210     -
   Landry Robert E SVP Finance & CFO   •       –      –    2015-08-05 4 S $591.78 $2,371,350 D/D (4,000) 7,099     -
   Landry Robert E SVP Finance & CFO   •       –      –    2015-08-05 4 OE $272.70 $1,090,800 D/D 4,000 11,099     -
   Tessier-Lavigne Marc Director   –       •      –    2015-08-05 4 S $584.07 $2,951,275 D/D (5,000) 1,187     -
   Tessier-Lavigne Marc Director   –       •      –    2015-08-05 4 OE $57.11 $285,550 D/D 5,000 6,187     -
   Mccorkle Douglas S VP Controller and Asst Treasur   •       –      –    2015-08-05 4 S $585.51 $2,927,648 D/D (5,000) 4,945     -
   Mccorkle Douglas S VP Controller and Asst Treasur   •       –      –    2015-08-05 4 OE $270.43 $1,352,150 D/D 5,000 9,745     -
   Goldstein Joseph L Director   –       •      –    2015-08-04 4 AS $586.00 $1,172,000 D/D (2,000) 14,000     -
   Gilman Alfred G Director   –       •      –    2015-07-31 4 A $0.00 $0 D/D 8,912 8,912     -
   Sanofi-Aventis 10% Owner   –       –       •   2015-07-27 4 AB $530.71 $5,718,272 I/I 10,639 22,869,783     -
   Goldstein Joseph L Director   –       •      –    2015-07-15 4 AS $550.00 $1,100,000 D/D (2,000) 16,000     -
   Vagelos P Roy Chairman of the Board   •       •      –    2015-07-01 4 GD $0.00 $0 I/I 414 154,390     -
   Goldstein Joseph L Director   –       •      –    2015-06-22 4 AS $526.85 $1,053,700 D/D (2,000) 18,000     -
   Stahl Neil EVP Research and Development   •       –      –    2015-05-28 4 GD $0.00 $0 D/D 1,000 16,405     -
   Sing George L Director   –       •      –    2015-05-27 4 S $515.00 $2,575,000 D/D (5,000) 112,772     -
  2430 Records found
  Previous  40  41  42  43  44  45  46  47  48  49  Next   
  Page 49 of 98
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us